Effects of bepagliflozin on renal function

Bepagliflozin is an SGLT2 inhibitor mainly used to treat 2 type diabetes. It lowers blood sugar levels by inhibiting the reabsorption of glucose by the renal tubules. Research suggests that bepagliflozin may have a positive impact on kidney function, reducing the risk of kidney complications in people with diabetes. However, caution is warranted when using bepagliflozin in individual patients, especially those with existing renal function problems. Doctors usually monitor a patient's kidney function, including blood creatinine levels and glomerular filtration rate, to ensure that the drug's effects on the kidneys are manageable. Patients should closely follow their physician's advice while using bepagliflozin and undergo regular renal function monitoring.